2-(7,8-Difluoronaphthalen-1-yl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane, 98%, 5g

4-(2-(Dipropylamino)ethyl)indolin-2-one hydrochloride, 99.0%, 5g

6-BROMO-5-FLUORO-2,3-DIHYDRO-1H-INDEN-1-OL, 95%, 100mg

n-Octane, min.99%, pour la synthèse, 500 ml, emballage en verre

5-PHENYL-1H-PYRROLE-3-CARBOXYLIC ACID, 95.0%, 250mg

CEFAZEDONE, 95%, 5g

N-Formyl-L-Leucine, PEPTIPURE®, min.98%, pour la biochimie, 1 g, emballage en verre

N,2-Dimethylbenzamide, 95.0%, 5g

N~1~-(4-fluoro-2-methylphenyl)glycinamide hydrochloride, 95.0%, 5g

6-BROMO-N-METHOXY-N-METHYLCHROMAN-2-CARBOXAMIDE, 95.0%, 250mg

4-(3-Fluoro-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)benzyl)morpholine, 95.0%, 1g

8-Bromo-3-methyl-1H-purine-2,6(3H,7H)-dione, 95.0%, 1g

Cartouches SPE CHROMAFIX® C18 ec, 0,4 ml, petite, 50 pièce(s)